The peripheral T‐cell neoplasms are a biologically and clinically heterogeneous group of
rare disorders that result from clonal proliferation of mature post‐thymic lymphocytes …

Primary diffuse large B-cell lymphoma (DLBCL) of the central nervous system is an
aggressive malignancy that exhibits unique biological features and characteristic clinical …

Secondary central nervous system (CNS) lymphoma (SCNSL) is defined by the involvement
of the CNS, either at the time of initial diagnosis of systemic lymphoma or in the setting of …

Background Standard treatment for patients with primary CNS lymphoma remains to be
defined. Active therapies are often associated with increased risk of haematological or …

1.4 Resource use 1.5 Implications for research 1.6 References 2.0 Recommendations and
auditable outcomes 2.1 Recommendations (GRADE) 2.1. 1 Patient involvement in decision …

Cytomegalovirus (CMV) remains an important cause of morbidity and mortality after
allogeneic stem cell transplantation (SCT), but cytotoxic T lymphocytes (CTL) may play a …

Summary Background The International Extranodal Lymphoma Study Group-32 (IELSG32)
trial is an international randomised phase 2 study that addresses two key clinical questions …

An analysis was performed of the response to treatment with donor lymphocyte infusions
(DLI) and the survival in 66 consecutive patients who relapsed after primary treatment by …

Background The combination of ibrutinib and venetoclax has been shown to improve
outcomes in patients with chronic lymphocytic leukemia (CLL) as compared with …

Purpose Adult T-cell leukemia-lymphoma (ATL) is a distinct mature T-cell malignancy
caused by chronic infection with human T-lymphotropic virus type 1 with diverse clinical …